Skip to main content
Erschienen in: Annals of Surgical Oncology 12/2016

30.06.2016 | Breast Oncology

Mucocele-Like Lesions of the Breast: Rate of Upstaging and Cancer Development

verfasst von: Waleed O. Gibreel, MBBS, Judy C. Boughey, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Breast mucocele-like lesions (MLLs) are rare breast lesions. There is a paucity of literature on the rate of pathologic upstaging of MLL to in situ or invasive breast cancer. We sought to review our experience with MLL at a tertiary care center and review published literature.

Methods

A retrospective review was undertaken of all patients with breast MLL at the Mayo Clinic, Rochester, from 1998 to 2016. Descriptive statistics were performed.

Results

Overall, 30 patients were diagnosed with MLL, with a mean age of 54.6 years (range 51–58). Calcifications on screening mammogram were the most common method of MLL detection (n = 26, 86.7 %), with core needle biopsy (CNB) being performed in 29/30 patients. MLL with atypia was identified in 14 patients (48 %), and surgical excision was performed in 26 patients. Disease was upstaged to invasive disease in one patient (3.8 %) who presented with a palpable mass. With a median duration of follow up of 3.5 years [interquartile range 1–7.1], two patients developed contralateral invasive breast cancer (both patients had a remote history of invasive breast cancer on that side), and one patient developed contralateral in situ disease. Review of the literature demonstrates a 2.9 % upgrade rate of MLL without atypia on excisional biopsy.

Conclusions

The upstage rate of MLL identified on CNB to invasive disease at surgical excision in this series was 3.8 %. In cases with MLL presenting as calcifications, no cases were upstaged in this series. Across the literature, upstage rates of MLL without atypia on CNB are low, indicating excisional biopsy may be avoided in these cases.
Literatur
2.
Zurück zum Zitat Ha D, Dialani V, Mehta TS, Keefe W, Iuanow E, Slanetz PJ. Mucocele-like lesions in the breast diagnosed with percutaneous biopsy: is surgical excision necessary? AJR Am J Roentgenol. 2015;204(1):204–10.CrossRefPubMed Ha D, Dialani V, Mehta TS, Keefe W, Iuanow E, Slanetz PJ. Mucocele-like lesions in the breast diagnosed with percutaneous biopsy: is surgical excision necessary? AJR Am J Roentgenol. 2015;204(1):204–10.CrossRefPubMed
3.
Zurück zum Zitat Neal L, Sandhu NP, Hieken TJ, Glazebrook KN, MacBride MB, Dilaveri CA, et al. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy. Mayo Clin Proc. 2014;89(4):536–47.CrossRefPubMed Neal L, Sandhu NP, Hieken TJ, Glazebrook KN, MacBride MB, Dilaveri CA, et al. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy. Mayo Clin Proc. 2014;89(4):536–47.CrossRefPubMed
4.
Zurück zum Zitat Sutton B, Davion S, Feldman M, Siziopikou K, Mendelson E, Sullivan M. Mucocele-like lesions diagnosed on breast core biopsy: assessment of upgrade rate and need for surgical excision. Am J Clin Pathol. 2012;138(6):783–8.CrossRefPubMed Sutton B, Davion S, Feldman M, Siziopikou K, Mendelson E, Sullivan M. Mucocele-like lesions diagnosed on breast core biopsy: assessment of upgrade rate and need for surgical excision. Am J Clin Pathol. 2012;138(6):783–8.CrossRefPubMed
5.
Zurück zum Zitat Zhao H, Morimoto T, Sasa M, Asato Y, Izumi K. Case reports of malignant mucocele-like lesions. Breast Cancer. 2002;9(1):86-90.CrossRefPubMed Zhao H, Morimoto T, Sasa M, Asato Y, Izumi K. Case reports of malignant mucocele-like lesions. Breast Cancer. 2002;9(1):86-90.CrossRefPubMed
6.
Zurück zum Zitat Kato M, Oda K, Kubota T, Akiyama F, Nimura Y. Mucocele-like tumor of the breast caused by ductal carcinoma in situ: a case report. Breast Cancer. 2003;10(2):157–62.CrossRefPubMed Kato M, Oda K, Kubota T, Akiyama F, Nimura Y. Mucocele-like tumor of the breast caused by ductal carcinoma in situ: a case report. Breast Cancer. 2003;10(2):157–62.CrossRefPubMed
7.
Zurück zum Zitat Berardi R, Latini L, Santinelli A, Herber N, Baldassarre S, Scartozzi M, et al. Mucocele-like tumour of the breast. J Exp Clin Cancer Res. 2003;22(2):329–32.PubMed Berardi R, Latini L, Santinelli A, Herber N, Baldassarre S, Scartozzi M, et al. Mucocele-like tumour of the breast. J Exp Clin Cancer Res. 2003;22(2):329–32.PubMed
8.
Zurück zum Zitat Lee JS, Kim HS, Jung JJ, Lee MC. Mucocele-like tumor of the breast associated with ductal carcinoma in situ and mucinous carcinoma: a case report. J Korean Med Sci. 2001;16(4):516–8.CrossRefPubMedPubMedCentral Lee JS, Kim HS, Jung JJ, Lee MC. Mucocele-like tumor of the breast associated with ductal carcinoma in situ and mucinous carcinoma: a case report. J Korean Med Sci. 2001;16(4):516–8.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Kim Y, Takatsuka Y, Morino H. Mucocele-like tumor of the breast: a case report and assessment of aspirated cytological specimens. Breast Cancer. 1998;5(3):317–20.CrossRefPubMed Kim Y, Takatsuka Y, Morino H. Mucocele-like tumor of the breast: a case report and assessment of aspirated cytological specimens. Breast Cancer. 1998;5(3):317–20.CrossRefPubMed
10.
Zurück zum Zitat Begum SM, Jara-Lazaro AR, Thike AA, Tse GM, Wong JS, Ho JT, et al. Mucin extravasation in breast core biopsies–clinical significance and outcome correlation. Histopathology. 2009;55(5):609–17.CrossRefPubMed Begum SM, Jara-Lazaro AR, Thike AA, Tse GM, Wong JS, Ho JT, et al. Mucin extravasation in breast core biopsies–clinical significance and outcome correlation. Histopathology. 2009;55(5):609–17.CrossRefPubMed
11.
Zurück zum Zitat Ramsaroop R, Greenberg D, Tracey N, Benson-Cooper D. Mucocele-like lesions of the breast: an audit of 2 years at BreastScreen Auckland (New Zealand). Breast J. 2005;11(5):321–5.CrossRefPubMed Ramsaroop R, Greenberg D, Tracey N, Benson-Cooper D. Mucocele-like lesions of the breast: an audit of 2 years at BreastScreen Auckland (New Zealand). Breast J. 2005;11(5):321–5.CrossRefPubMed
12.
Zurück zum Zitat Carkaci S, Lane DL, Gilcrease MZ, Conrow D, Schwartz MR, Huynh P, et al. Do all mucocele-like lesions of the breast require surgery? Clin Imaging. 2011;35(2):94–101.CrossRefPubMed Carkaci S, Lane DL, Gilcrease MZ, Conrow D, Schwartz MR, Huynh P, et al. Do all mucocele-like lesions of the breast require surgery? Clin Imaging. 2011;35(2):94–101.CrossRefPubMed
13.
Zurück zum Zitat Deschryver K, Radford DM, Schuh ME. Pathology of large-caliber stereotactic biopsies in nonpalpable breast lesions. Semin Diagn Pathol. 1999;16(3):224–34.PubMed Deschryver K, Radford DM, Schuh ME. Pathology of large-caliber stereotactic biopsies in nonpalpable breast lesions. Semin Diagn Pathol. 1999;16(3):224–34.PubMed
14.
Zurück zum Zitat El-Sayed ME, Rakha EA, Reed J, Lee AH, Evans AJ, Ellis IO. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology. 2008;53(6):650–7.CrossRefPubMed El-Sayed ME, Rakha EA, Reed J, Lee AH, Evans AJ, Ellis IO. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology. 2008;53(6):650–7.CrossRefPubMed
15.
Zurück zum Zitat Flegg KM, Flaherty JJ, Bicknell AM, Jain S. Surgical outcomes of borderline breast lesions detected by needle biopsy in a breast screening program. World J Surg Oncol. 2010;8:78.CrossRefPubMedPubMedCentral Flegg KM, Flaherty JJ, Bicknell AM, Jain S. Surgical outcomes of borderline breast lesions detected by needle biopsy in a breast screening program. World J Surg Oncol. 2010;8:78.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Weigel S, Decker T, Korsching E, Biesheuvel C, Wostmann A, Bocker W, et al. Minimal invasive biopsy results of “uncertain malignant potential” in digital mammography screening: high prevalence but also high predictive value for malignancy. Rofo. 2011;183(8):743–8.CrossRefPubMed Weigel S, Decker T, Korsching E, Biesheuvel C, Wostmann A, Bocker W, et al. Minimal invasive biopsy results of “uncertain malignant potential” in digital mammography screening: high prevalence but also high predictive value for malignancy. Rofo. 2011;183(8):743–8.CrossRefPubMed
17.
Zurück zum Zitat Park YJ, Kim EK. A pure mucocele-like lesion of the breast diagnosed on ultrasonography-guided core-needle biopsy: is imaging follow-up sufficient? Ultrasonography. 2015;34(2):133–8.CrossRefPubMed Park YJ, Kim EK. A pure mucocele-like lesion of the breast diagnosed on ultrasonography-guided core-needle biopsy: is imaging follow-up sufficient? Ultrasonography. 2015;34(2):133–8.CrossRefPubMed
18.
Zurück zum Zitat Diorio C, Provencher L, Morin J, Desbiens C, Poirier B, Poirier E, et al. Is there an upgrading to malignancy at surgery of mucocele-like lesions diagnosed on percutaneous breast biopsy? Breast J. 2016;22(2):173–9.CrossRefPubMed Diorio C, Provencher L, Morin J, Desbiens C, Poirier B, Poirier E, et al. Is there an upgrading to malignancy at surgery of mucocele-like lesions diagnosed on percutaneous breast biopsy? Breast J. 2016;22(2):173–9.CrossRefPubMed
19.
Zurück zum Zitat Wang J, Simsir A, Mercado C, Cangiarella J. Can core biopsy reliably diagnose mucinous lesions of the breast? Am J Clin Pathol. 2007;127(1):124–7.CrossRefPubMed Wang J, Simsir A, Mercado C, Cangiarella J. Can core biopsy reliably diagnose mucinous lesions of the breast? Am J Clin Pathol. 2007;127(1):124–7.CrossRefPubMed
20.
Zurück zum Zitat Renshaw AA. Can mucinous lesions of the breast be reliably diagnosed by core needle biopsy? Am J Clin Pathol. 2002;118(1):82–4.CrossRefPubMed Renshaw AA. Can mucinous lesions of the breast be reliably diagnosed by core needle biopsy? Am J Clin Pathol. 2002;118(1):82–4.CrossRefPubMed
21.
Zurück zum Zitat Rakha EA, Shaaban AM, Haider SA, Jenkins J, Menon S, Johnson C, et al. Outcome of pure mucocele-like lesions diagnosed on breast core biopsy. Histopathology. 2013;62(6):894–8.CrossRefPubMed Rakha EA, Shaaban AM, Haider SA, Jenkins J, Menon S, Johnson C, et al. Outcome of pure mucocele-like lesions diagnosed on breast core biopsy. Histopathology. 2013;62(6):894–8.CrossRefPubMed
22.
Zurück zum Zitat Jaffer S, Bleiweiss IJ, Nagi CS. Benign mucocele-like lesions of the breast: revisited. Mod Pathol. 2011;24(5):683–7.CrossRefPubMed Jaffer S, Bleiweiss IJ, Nagi CS. Benign mucocele-like lesions of the breast: revisited. Mod Pathol. 2011;24(5):683–7.CrossRefPubMed
23.
Zurück zum Zitat Ouldamer L, Body G, Arbion F, Avigdor S, Michenet P. Mucocele-like lesions of the breast: management after diagnosis on ultrasound guided core biopsy or stereotactic vacuum-assisted biopsy [in French]. Gynecol Obstet Fertil. 2010;38(7-8):455–9.CrossRefPubMed Ouldamer L, Body G, Arbion F, Avigdor S, Michenet P. Mucocele-like lesions of the breast: management after diagnosis on ultrasound guided core biopsy or stereotactic vacuum-assisted biopsy [in French]. Gynecol Obstet Fertil. 2010;38(7-8):455–9.CrossRefPubMed
24.
Zurück zum Zitat Carder PJ, Murphy CE, Liston JC. Surgical excision is warranted following a core biopsy diagnosis of mucocoele-like lesion of the breast. Histopathology. 2004;45(2):148–54.CrossRefPubMed Carder PJ, Murphy CE, Liston JC. Surgical excision is warranted following a core biopsy diagnosis of mucocoele-like lesion of the breast. Histopathology. 2004;45(2):148–54.CrossRefPubMed
25.
Zurück zum Zitat Glazebrook K, Reynolds C. Original report. Mucocele-like tumors of the breast: mammographic and sonographic appearances. AJR Am J Roentgenol. 2003;180(4):949–54.CrossRefPubMed Glazebrook K, Reynolds C. Original report. Mucocele-like tumors of the breast: mammographic and sonographic appearances. AJR Am J Roentgenol. 2003;180(4):949–54.CrossRefPubMed
Metadaten
Titel
Mucocele-Like Lesions of the Breast: Rate of Upstaging and Cancer Development
verfasst von
Waleed O. Gibreel, MBBS
Judy C. Boughey, MD
Publikationsdatum
30.06.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 12/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5352-7

Weitere Artikel der Ausgabe 12/2016

Annals of Surgical Oncology 12/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.